300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Tajikistan
Tunisia
Romania
Oman
Puerto Rico
Poland
Andorra
Guernsey
Cameroon
Sudan
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Bermuda
Asia
Dominican Republic
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 35 Life Science VC Funds & Investors in Singapore (September 2026)

The most active venture capital funds investing in Singapore Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Singapore Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
3 Japan, United States, India Seed, Series A, Series B Health Care, Biotechnology, Medical $900k–$27M
Anzu Partners
VC Fund
3 United States, Canada, Spain Series A, Series B, Venture - Series Unknown Software, Biotechnology, Manufacturing $5M–$44M
Antler
VC Fund
3 Singapore, Australia, United Kingdom Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $100k–$29M
EDBI
VC Fund
3 United States, Singapore, India Series C, Series B, Series D Biotechnology, Software, Health Care $10M–$400M
Partners Investment
VC Fund
2 South Korea, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Software $2.7M–$98M
Bossa Invest
VC Fund
2 United States, Brazil, Mexico Seed, Pre-Seed, Venture - Series Unknown Software, Information Technology, Financial Services $50k–$36M
Eisai
VC Fund
2 Japan, United States, China Series A, Series C, Grant Medical, Biotechnology, Health Care $881k–$100M
SK Securities
VC Fund
1 South Korea, United States, Singapore Series A, Seed, Series B Apps, Health Care, Information Technology $316k–$24M
Alameda Research
VC Fund
1 United States, Singapore, United Kingdom Seed, Venture - Series Unknown, Series A Blockchain, Cryptocurrency, Financial Services $250k–$40M
Shinhan Investment
VC Fund
1 South Korea, United States, Bermuda Series A, Series B, Series C Health Care, Manufacturing, Information Technology $20k–$106M
Animoca Brands
VC Fund
1 United States, United Kingdom, Singapore Seed, Series A Blockchain, Gaming, Cryptocurrency $1.3M–$40M
Lightstone Ventures
VC Fund
1 United States, Ireland, India Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $18M–$105M
Medici Investment
VC Fund
1 South Korea, Canada, Singapore Series A, Series C, Series B Biotechnology, Information Technology, Software $861k–$250M
The Venture Collective
VC Fund
1 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Health Care, Biotechnology, Artificial Intelligence $410k–$32M
Prox Ventures
VC Fund
1 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $2.5M–$28M
Altara Ventures
VC Fund
1 Indonesia, Singapore, Philippines Series A, Series B, Series C FinTech, Information Technology, Banking $3.9M–$70M
Hana Financial Investment
VC Fund
1 South Korea, Singapore, India Series A, Series B, Seed Biotechnology, Information Technology, Artificial Intelligence $213k–$28M
Openspace Capital
VC Fund
1 Singapore, Indonesia, Philippines Series A, Series B, Seed E-Commerce, Financial Services, Software $1.7M–$55M
Seeds Capital
VC Fund
1 Singapore, United States, Hong Kong Seed, Series A, Series B Biotechnology, Artificial Intelligence, Health Care $767k–$45M
K3 Ventures
VC Fund
1 Singapore, United States, Indonesia Series A, Seed, Venture - Series Unknown Financial Services, FinTech, Software $1M–$2.5B
Temasek
VC Fund
1 United States, China, India Series B, Series C, Series D Biotechnology, Health Care, Software $29M–$450M
Hatcher+
VC Fund
1 United States, Italy, Australia Pre-Seed, Seed, Convertible Note Software, Information Technology, Health Care $50k–$1.5M
Elev8.VC
VC Fund
1 Singapore, United States, Germany Seed, Series A Health Care, Software, Biotechnology $1M–$13M
Amgen Ventures
VC Fund
1 United States, Canada, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $4.4M–$110M
KB Financial Group
VC Fund
1 South Korea, India, Vietnam Series A, Series B, Series D Financial Services, Software, SaaS $1M–$220M
Nestle
VC Fund
1 United States, United Kingdom, Germany Private Equity, Corporate Round, Grant Food and Beverage, Health Care, Food Processing $6k–$4.2B
M Capital Partners
VC Fund
1 France, United States, Canada Seed, Venture - Series Unknown Health Care, Software, Food and Beverage $1.1M–$5.7M
Arche Investment
VC Fund
1 South Korea, Singapore Series B, Series A Biotechnology, Pet, Apps $16M–$27M
IBK Capital
VC Fund
1 South Korea, United States, India Series A, Seed, Series B Health Care, Biotechnology, Information Technology $436k–$17M
10X Capital
VC Fund
1 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Software, Health Care, FinTech $800k–$36M
NPR Holdings
VC Fund
1 Singapore Venture - Series Unknown Medical, Life Science, Biotechnology
Entrepreneurs First
VC Fund
1 United Kingdom, United States, India Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $55k–$30M
Enterprise Singapore
VC Fund
1 Singapore, United States, United Kingdom Grant, Seed, Pre-Seed Information Technology, Software, Artificial Intelligence $22k–$1.8M
Gaorong Capital
VC Fund
1 China, United States, Hong Kong Series A, Series B, Seed Information Technology, Software, Artificial Intelligence $2.8M–$120M
KT Investment
VC Fund
1 South Korea, United States, Singapore Series A, Series B, Series C Artificial Intelligence, Software, Information Technology $2M–$124M
Access all 59 VC funds in Singapore Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

UTEC - The University of Tokyo Edge Capital Partners
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Singapore Life Science startups

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Series B
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 204
  • Round size: Seed $900k–$14M; Series A $2.3M–$18M; Series B $3.1M–$27M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely actively investing — fresh fund, raised $326M in 2025

Portfolio highlights

  • Mujin — At Mujin, we design automation platforms to enhance any robot, enable advanced capabilities and lower operating costs.
  • Sinumy — Sinumy develops touchless identity authentication technology and high-speed, high-precision position measurement technology.
  • X Mile — Corporate Site:https://www.xmile.co.jp/ Service Site:https://x-work.jp/
Show all investments...

Anzu Partners
VC Fund · Washington, District of Columbia, United States · 3 investments in Singapore Life Science startups

Anzu Partners invests in breakthrough clean tech, industrial, and life science technologies with $1B in assets under management across venture, credit, and public structures.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, Canada, Spain

Investor stats

  • Total investments: 83
  • Round size: Series A $6M–$25M; Series B $5M–$44M; Venture - Series Unknown $8.1M–$21M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $100M in 2024

Portfolio highlights

  • CytoTronics — CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.
  • EnCharge AI — AI Compute from the Edge-to-Cloud for Every Business. Transformative technology for AI computation, breaking records in efficiency and sustainability to enable state-of-the-art models uninhibited by power, space, and cost constraints.
  • South 8 Technologies — South 8's LiGas cells are engineered to deliver unmatched performance and safety in the most demanding environments.
Show all investments...

Antler
VC Fund · Singapore, Central Region, Singapore · 3 investments in Singapore Life Science startups

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Singapore, Australia, United Kingdom

Investor stats

  • Total investments: 2372
  • Round size: Seed $158k–$4.5M; Pre-Seed $100k–$587k; Series A $4.1M–$29M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026

Portfolio highlights

  • Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
  • Forti Foods — The mission of Forti Foods is to enhance communities and change lives beyond the plate by fostering resilience and dignity via sustainable food innovation.
  • RubiLabs — RubiLabs Inc provides a platform for unifying, monitoring, and analyzing organizational data. RubiLabs software enables analysts and operators across risk, compliance, and security teams to collaborate and interpret large volumes of information in real time. The company’s platform is designed to help institutions make sense of complex, fragmenteddata by transforming it into a coherent operational picture for risk detection, continuous monitoring, and investigative workflows.
Show all investments...

EDBI
VC Fund · Singapore, Central Region, Singapore · 3 investments in Singapore Life Science startups

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series C, Series B, Series D
  • Geography: United States, Singapore, India

Investor stats

  • Total investments: 199
  • Round size: Series B $20M–$170M; Series C $10M–$275M; Series D $17M–$400M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Deepgram — Deepgram helps enterprises unlock the potential of their audio data with custom-trained speech recognition for accuracy and scale. Deepgram's deep learning speech recognition system searches for keywords in transcripts by sound and text within audio and video files, used for transcribing calls, meetings, and voicemails for searchable notes,providing businesses with a fast, high accuracy speech-to-text on an easy-to-use API.The company was founded in 2015 and is headquartered in San Francisco, California.
  • Horizon3.ai — Horizon3.ai's mission is to help you find and fix your attack vectors before criminals exploit them. NodeZero, our automated penetration testing solution, enables organizations to continuously assess the security posture of their enterprise, including external, identity, on-prem, IoT, and cloud attack surfaces. Like APTs, ransomware, andother threat actors, our algorithms discover and fingerprint your attack surface, identifying the ways exploitable vulnerabilities, misconfigurations, harvested credentials, and dangerous product defaults can be chained together to facilitate a compromise. NodeZero is a true self-service SaaS offering that is safe to run in production and requires no persistent or credentialed agents. You will see your enterprise through the eyes of the attacker, identify your ineffective security controls, and ensure your limited resources are spent fixing problems that can actually be exploited. Founded in 2019 by industry, US Special Operations, and US National Security veterans, Horizon3.ai is headquartered in San Francisco, CA, and made in the USA.
  • TriReme Medical — TriReme Medical, Inc. (TMI) is a privately held medical device company based in Pleasanton, California. Founded in 2005, it is dedicated to the development and manufacturing of novel stent technologies for the treatment of coronary artery disease (CAD) at or near bifurcations.
Show all investments...

Partners Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in Singapore Life Science startups

As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 131
  • Round size: Series A $2.7M–$30M; Series B $5.5M–$98M; Series C $7.4M–$87M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely still investing — raised $190M in 2023

Portfolio highlights

  • XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
  • Solivis — Solivis is the manufacturer of solid-state batteries designed for next-generation battery packs. The company's product is used as a secondary battery for electric vehicles and has developed a wet synthesis method that can mass-produce a sulfide-based solid electrolyte with homogeneous high ionic conductivity, enabling clients to significantlyimprove productivity by reducing process costs and shortening the synthesis time.
  • Remember & Company — Remember & Company develops professional networking, recruitment, and business relationship management services through its Remember platform and related enterprise solutions. The company provides digital business card management tools that allow users to scan, organize, and update professional contact information through mobile applicationsand cloud-based systems. It also operates recruitment and headhunting services that connect companies with experienced professionals through talent discovery, scouting, and hiring workflows.Remember & Company develops expert network and research services that link businesses with industry specialists for interviews, surveys, and market insight projects. The platform includes community, networking, and business engagement features designed to support professional interaction and relationship-building among working professionals. In addition, Remember & Company offers advertising, corporate marketing, and business solution services targeted toward professional and enterprise audiences.
Show all investments...

Bossa Invest
VC Fund · São Paulo, Sao Paulo, Brazil · 2 investments in Singapore Life Science startups, 33 in the past 12 months

Aprenda a Investir em Startups

Show more...

Investment focus

  • Industry: Software, Information Technology, Financial Services
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United States, Brazil, Mexico

Investor stats

  • Total investments: 2047
  • Round size: Seed $178k–$5.8M; Pre-Seed $50k–$2M; Venture - Series Unknown $632k–$36M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • FFID — FFID develops AI chatbot platform automating customer communication, lead generation, and marketing workflows.
  • SprayX — Company specialized in interactive process control to evaluate and guarantee the quality of agricultural spraying with excellence. Empowers, leads and monitors applicators in Application Technology tasks.
  • Sandwiche — Sandwiche creates customizable link in bio pages enabling social media monetization and affiliate marketing management.
Show all investments...

Eisai
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Singapore Life Science startups

Eisai is a human healthcare company that provides products and services to its patients and their families under any healthcare system. They specialize in an integrated pharmaceutical business that operates in business groups and focuses on oncology and neurology, dementia-related diseases, and neurodegenerative diseases.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Series A, Series C, Grant
  • Geography: Japan, United States, China

Investor stats

  • Total investments: 20
  • Round size: Series A $3M–$51M; Series C $881k–$100M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Medefer — At Medefer, we want to be the world’s most patient-focused virtual health serviceWe are on a mission to help patients get better faster. We are starting by partnering with the NHS to build the best outpatient process, helping assess patients more quickly.To do this work with our partners, we provide technology-enabled clinical and operationalexpertise, making it better for patients, healthcare professionals and the NHS.
  • Head Diagnostics — Innovating Brain Health, Transforming Lives. We empower you with clinically validated AI-driven digital solutions designed to support diagnosis and enhance the detection and management of neurological disease with a focus on cognitive assessment
  • Beren Therapeutics — Founded to serve patients through transformative medicines
Show all investments...

SK Securities
VC Fund · Yongdungpo, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955.

Show more...

Investment focus

  • Industry: Apps, Health Care, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 54
  • Round size: Seed $316k–$2.2M; Series A $1.5M–$24M; Series B $5.7M–$24M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • InnoDtech — InnoDtech creates AI dental diagnostics and clear orthodontic aligners using 3D imaging, modeling, and personalized treatment planning.
  • Quantum AI — Quantum AI is an AI data company that offers offline and online data collection and analysis services. Currently, Quantum AI is providing various services centered on the financial sector, including AI document processing automation, intelligent voice consultation, assetization of unstructured financial data based on its own language model, and AIsearch. Utilizing a proprietary AI recognition engine, the company has integrated and analyzed various data sources, including financial documents, customer consultation history, and market news, and have carried out numerous AI data assetization projects for major domestic commercial banks and insurance companies.
  • Buysell Standards — Buysell Standards is the provider of manpower supply and employment arrangement services.
Show all investments...

Alameda Research
VC Fund · Central and Western, Hong Kong Island, Hong Kong · 1 investments in Singapore Life Science startups

Alameda Research is a quantitative cryptocurrency trading firm that provides liquidity in cryptocurrency and digital assets markets. It was founded in 2017 and is headquartered in Central and Western, Hong Kong.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Financial Services
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United States, Singapore, United Kingdom

Investor stats

  • Total investments: 327
  • Round size: Seed $1M–$8M; Series A $2.7M–$35M; Venture - Series Unknown $250k–$40M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • 3Commas — 3Commas develops a crypto-asset management tool for tracking investments and exchanges in a unified platform. It provides access to a unified dashboard as the central hub for trading and portfolio management execution.
  • Fuel Labs — At Fuel, we are building the fastest execution layer for the modular blockchain stack.
  • Optim Finance — Optim Finance provides investment tools that optimize yield on digital assets. Their financial primitives enable users to rent ADA delegation rights to power novel use cases such as SPO loans, leverage into ISOs, and initial bonds.
Show all investments...

Shinhan Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

Shinhan Investment Corp. is a financial services company based out of 여의대로 70, 영등포구, 서울특별시, South Korea.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Bermuda

Investor stats

  • Total investments: 41
  • Round size: Series A $1.7M–$23M; Series B $20k–$52M; Series C $8M–$106M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Inocras — Unlock the potential of a Whole Genome Sequencing Test with Inocras. Transforming diagnosis and treatment for cancer and rare diseases.
  • Sensor Tower — Sensor Tower provides market intelligence and analytics for the mobile app economy through their software suite. It serves independent and Fortune 500 customers alike, spanning the mobile games, travel, music, finance, eCommerce, and entertainment markets. Our suite consists of free, SMB, and Enterprise level solutions including Store Intelligence,Usage Intelligence, Ad Intelligence, and App Intelligence.
  • Woori Technology — We, Woori Technology, are trying our best to satisfy customers with continuous R&D and innovation.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Animoca Brands
VC Fund · Cyberport, Hong Kong Island, Hong Kong · 1 investments in Singapore Life Science startups

Animoca Brands is a metaverse and gaming venture capital firm that focuses on driving digital property rights to gamers and internet users through NFTs. It utilizes gamification and blockchain to develop and market a portfolio of mobile applications, games, and additional products oriented to educational learning to ensure transparency, security,and new business models.

Show more...

Investment focus

  • Industry: Blockchain, Gaming, Cryptocurrency
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Singapore

Investor stats

  • Total investments: 517
  • Round size: Seed $1.3M–$10M; Series A $5M–$40M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Vangrid — Vangrid operates as a decentralized physical infrastructure network.
  • Slinky Network — Slinky Network provides an on-chain marketplace and payment protocol that connects AI agents and applications with third-party APIs. The company offers the SlinkyLayer platform, which wraps developer endpoints as discoverable skills and exposes them through an x402 pay-per-execution interface. Each API call triggers a non-custodial on-chainmicropayment, settling in the same request loop using networks such as Base and BNB Chain. Developers set prices, earn a defined revenue share, and receive instant payouts to their wallets without subscriptions or custodial holds. AI agents authenticate via wallet signatures, enabling autonomous, machine-to-machine access and payment without traditional logins or credit cards. The platform also records call ratings on-chain to provide portable, verifiable reputation for services.
  • Ceramic Network — We've joined @textileio to build the first open intelligence network for AI agents. Follow us there.
Show all investments...

Lightstone Ventures
VC Fund · Menlo Park, California, United States · 1 investments in Singapore Life Science startups

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Ireland, India

Investor stats

  • Total investments: 88
  • Round size: Series A $20M–$95M; Series B $18M–$100M; Series C $20M–$105M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • Cerevance — Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases, including chronic neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Using a large and growing repository of over 15,000 human brain tissue samples, thecompany generates an unprecedented level of expression and epigenetic data, enabling the company to identify the most promising targets for the next generation of treatments for CNS disorders.
  • Psivant Therapeutics — PsiThera is advancing programs across multiple targets from the TNF superfamily and beyond, where no oral therapies currently exist.
  • Crystalys Therapeutics — Transforming care for people living with gout.
Show all investments...

Medici Investment
VC Fund · 1 investments in Singapore Life Science startups

Venture Capital firm in South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Software
  • Stage:Series A, Series C, Series B
  • Geography: South Korea, Canada, Singapore

Investor stats

  • Total investments: 38
  • Round size: Series A $861k–$18M; Series B $7.8M–$27M; Series C $2.9M–$250M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • MID — MID specializes in the development, testing, and production of space-related components.
  • RebuilderAI — A new way to bring imagination into the real world
  • Destin Power — Destin Power manufactures power conditioning products designed to improve energy management and safety. The company created the ESS system by utilizing core power electronics technology such as control technology for energy storage systems, static and dynamic grid support technology, and micro-grid inverter technology.
Show all investments...

The Venture Collective
VC Fund · New York, New York, United States · 1 investments in Singapore Life Science startups

TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 55
  • Round size: Seed $2.7M–$20M; Pre-Seed $410k–$1.9M; Series A $10M–$32M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Orbem — Transform biological imaging with AI-powered MRI technology. Non-invasive solutions for poultry, fruits, nuts, and health. Building a sustainable future.
  • Cocoon — Low carbon construction materials for the builders of tomorrow.
  • Unnatural Products — Unnatural Products is a startup pairing AI with chemistry to create treatments for drug targets. Its AI-enhanced technology platform creates entirely new drugs by engineering passively permeable, macrocyclic peptides that access traditionally undruggable targets.Unnatural Products was founded in 2017 and is headquartered in Santa Cruz,California.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 1 investments in Singapore Life Science startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 82
  • Round size: Seed $2.5M–$14M; Series A $3M–$28M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Shengxin Medical — Shengxin Medical is a cardiovascular interventional medical device developer, dedicated to creating innovative, high-quality solutions that improve the diagnosis, treatment, and management of cardiovascular diseases, while advancing minimally invasive medical technologies to enhance patient outcomes and clinical efficiency.
  • Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
  • Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Show all investments...

Altara Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Singapore-based venture firm backing Series A & B companies across Southeast Asia. Built by operators for founders who understand the long climb. Global perspective, local instincts.

Show more...

Investment focus

  • Industry: FinTech, Information Technology, Banking
  • Stage:Series A, Series B, Series C
  • Geography: Indonesia, Singapore, Philippines

Investor stats

  • Total investments: 25
  • Round size: Series A $4.5M–$21M; Series B $3.9M–$40M; Series C $12M–$70M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely still investing — raised $130M in 2022

Portfolio highlights

  • Saturdays — Shop for premium quality glasses at affordable prices with free shipping and 30-day return policy. Find your perfect pair with SATURDAYS LIFESTYLE.
  • Netbank — Netbank provides various banking solutions like alternative lenders, payment solutions, neobanks, and wallets.
  • PolicyStreet — Renew your insurance and road tax instantly, hassle-free. We're the BEST, but don't just take our word for it. See what our happy customers have to say!
Show all investments...

Hana Financial Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, Singapore, India

Investor stats

  • Total investments: 93
  • Round size: Seed $213k–$9.6M; Series A $2M–$26M; Series B $1.7M–$28M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Trustay — Trustay is a real estate asset management company.
  • earlysloth — Earlysloth is an AI based survey on the messenger for the enterprise.
  • Kimu Studio — Kimu discovers servant artists, plans education and exhibitions with the artist's unique sensibility.
Show all investments...

Openspace Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Software
  • Stage:Series A, Series B, Seed
  • Geography: Singapore, Indonesia, Philippines

Investor stats

  • Total investments: 136
  • Round size: Seed $2.6M–$13M; Series A $1.7M–$20M; Series B $10M–$55M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $25M in 2022

Portfolio highlights

  • Every Half Coffee Roasters — Roasting & Brewing finest quality of specialty coffee bean from Vietnam and the world. We believe that every half bean has its soulmate. Let's find yours
  • Eunice — Eunice combines extensive on-chain data with powerful off-chain insights to provide a customisable, AI-driven due diligence and monitoring solution
  • Video Rebirth — Video Rebirth Limited is a private limited company that is established with shares.
Show all investments...

Seeds Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Catalysing smart monies into Singapore-based, early-stage technology startups.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Singapore, United States, Hong Kong

Investor stats

  • Total investments: 147
  • Round size: Seed $767k–$6M; Series A $2.4M–$21M; Series B $5M–$45M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Pinta AI — Pinta AI provides an AI security platform focused on monitoring and controlling AI agents, coding tools, and Model Context Protocol workflows. The platform operates at the runtime layer to track prompts, tool calls, JSON-RPC messages, and outcomes tied to individual users. It gives security teams execution visibility across servers, agents, tools,and resources, including unauthorized or shadow AI setups. Pinta AI detects risky or high-impact actions such as access to sensitive data or critical system resources and surfaces them as security alerts. The software maintains detailed audit trails with identity, tools, timestamps, and actions to support investigation and compliance. It is designed to integrate with existing AI stacks and security operations without requiring major changes to current workflows.
  • ChemT Biotechnology — The goal of ChemT Biotechnology is to increase patient access to the most cutting-edge biologics, beginning with the urgent issues in manufacturing and research and development.
  • Protuoso Biosciences — Protuoso Bio is a pioneering biotechnology company developing Next-Gen MUXBODIES for Complex Diseases. We leverage AI-driven protein engineering and synthetic biology to advance innovative oncology drug research.
Show all investments...

K3 Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Software
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Singapore, United States, Indonesia

Investor stats

  • Total investments: 108
  • Round size: Seed $1.2M–$20M; Series A $2M–$100M; Venture - Series Unknown $1M–$2.5B
  • Lead/follow: 9% lead, 91% follow
  • Last fund: Likely still investing — raised $147M in 2021

Portfolio highlights

  • iEduGPT — iEduGPT is an AI-powered learning platform based in Singapore that offers personalized, adaptive learning solutions for professional and academic exam preparation. It leverages artificial intelligence to analyze individual learners' strengths and knowledge gaps and create optimized study paths. The platform aims to transform exam preparationby making learning smarter, more efficient, and tailored to each user’s unique needs, covering certifications in finance, academics, and languages.
  • Rekosistem — Rekosistem is a Clean- & Climate-Tech Company that enables circular economy implementation in the waste supply chain by leveraging proprietary waste management operation systems to transform waste into recycled materials and renewable resources.
  • Octopus Power — Octopus Power develops physics-based artificial intelligence systems focused on physical AGI, enabling machines to perceive, reason, and act within real-world environments. The company builds models that integrate physical laws with data-driven learning to support embodied intelligence, allowing systems to interact with and adapt to dynamicphysical conditions. Its technology is designed to move beyond purely digital AI by incorporating simulation, control systems, and real-world feedback loops into intelligent decision-making.The platform supports applications in robotics, industrial automation, and complex physical systems where understanding motion, force, and environmental constraints is essential. It leverages continuous learning mechanisms that allow systems to evolve over time, improving performance through interaction and data accumulation. Octopus Power also develops infrastructure for training and deploying these models, including simulation environments and tools for integrating AI with physical hardware.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Temasek
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups, 39 in the past 12 months

Temasek is a global investment company headquartered in Singapore with a multinational staff of over 960 people. Our portfolio is valued at S$434 billion.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series C, Series D
  • Geography: United States, China, India

Investor stats

  • Total investments: 641
  • Round size: Series B $29M–$250M; Series C $30M–$400M; Series D $43M–$450M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — raised $283M in 2019

Portfolio highlights

  • River AI — River AI develops personal AI technologies and provides an API for training and adapting open-source AI models. Its API supports LoRA-based fine-tuning and reinforcement learning, allowing users to train, sample, and serve customized models using their own data and rewards. The company also develops personalization, continual learning, AIinfrastructure, and personal hardware for AI systems designed to operate under individual user control.
  • Rize — Rize is an AgTech startup formed through a joint venture between Temasek, Wavemaker Impact, Breakthrough Energy Ventures, GenZero to decarbonize rice cultivation in Asia.
  • Databricks — Databricks offers a unified platform for data, analytics and AI. Build better AI with a data-centric approach. Simplify ETL, data warehousing, governance and AI on the Data + AI Platform.
Show all investments...

Hatcher+
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Hatcher+ is a data-driven venture capital firm that uses AI and machine learning-based technologies to identify early-stage opportunities in partnership with leading accelerators and investors, worldwide.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Pre-Seed, Seed, Convertible Note
  • Geography: United States, Italy, Australia

Investor stats

  • Total investments: 192
  • Round size: Seed $50k–$1.5M; Pre-Seed $50k–$1.2M
  • Lead/follow: 61% lead, 39% follow

Portfolio highlights

  • Inaam — impact investing made simple. pick your values, build a real portfolio, track where your money goes. $10/month. ASIC-regulated. built for 18-30s.
  • PayToMe.co — PayToMe.co offers innovative and secure payment solutions including text-to-pay, digital invoicing, and digital checkbook services.
  • Kybele's Garden — Kybele's Garden focus on algae-based bioponics and algae fermentation methods. Their differentiation strategy boosts harvest yield, source efficiency, and functional content, while improving sensory attributes and shelf life. These technologies can be used in agrifood and skin care, and integrated into existing producers' systems.
Show all investments...

Elev8.VC
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Deep Dive Into Deep Tech

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Series A
  • Geography: Singapore, United States, Germany

Investor stats

  • Total investments: 26
  • Round size: Seed $1M–$4.8M; Series A $3.5M–$13M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely actively investing — fresh fund, raised $30M in 2025

Portfolio highlights

  • Polybee — Polybee develops autonomous drone systems designed for agricultural applications. They focus on automating yield forecasting and pollination using drones, computer vision, and artificial intelligence. Their technology aims to reduce uncertainty in agriculture by providing solutions for seed companies, vertical farming operations, and greenhousecooperatives. Polybee's innovations are particularly useful in environments.
  • Terra Oleo — Terra Oleo pioneers microbial technology to create sustainable fats & oils, offering cost-effective alternatives to palm oil & cocoa butter.
  • 2Strands Biosciences — Better, Cheaper and Faster!
Show all investments...

Amgen Ventures
VC Fund · San Francisco, California, United States · 1 investments in Singapore Life Science startups

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 117
  • Round size: Series A $4.4M–$53M; Series B $11M–$110M; Series C $19M–$80M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2012

Portfolio highlights

  • EnClear Therapies — EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will targetimproving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).
  • Ember LifeSciences — Ember LifeSciences is a healthcare technology company that develops cold chain solutions to support the safe transport of temperature-sensitive medicines, vaccines, and biologics using proprietary temperature control systems. The company’s core offering includes the Ember Cube. This self-refrigerated and cloud-connected shipping container providescontinuous temperature monitoring, GPS tracking, and real-time data reporting to maintain drug efficacy during transit. Ember LifeSciences leverages its engineering expertise in thermal management and digital monitoring to develop modular shipping solutions that can replace traditional single-use cold chain packaging, thereby reducing waste. It works with pharmaceutical distributors, specialty pharmacies, and laboratories by enabling visibility and control over critical environmental conditions throughout distribution. The company continues to develop next-generation versions of its devices, incorporating improved insulation and configurable features to support broader supply chain use cases.
  • Mindset Medical — Medical Mindset is your health companion. It is a platform for you to track your health and wellness.
Show all investments...

KB Financial Group
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services.

Show more...

Investment focus

  • Industry: Financial Services, Software, SaaS
  • Stage:Series A, Series B, Series D
  • Geography: South Korea, India, Vietnam

Investor stats

  • Total investments: 14
  • Round size: Series A $1M–$45M; Series B $7.8M–$128M; Series D $182M–$220M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Nitra — Nitra offers expense management software that integrates with the banks to provide innovative loan products.
  • Wavebridge — Wavebridge is a top-tier institutional digital asset company with expertise in both traditional and crypto finance. The company was established in November 2018 to provide a comprehensive suite of investment solutions utilizing its data processing and AI technology.
  • Ohouse — No.1 Interior Onestop Platform
Show all investments...

Nestle
VC Fund · Vevey, Vaud, Switzerland · 1 investments in Singapore Life Science startups

Nestle manufactures and sells food and beverages for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestle, Nescafe, Perrier, Pure Life, and Purina. Nestle also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.

Show more...

Investment focus

  • Industry: Food and Beverage, Health Care, Food Processing
  • Stage:Private Equity, Corporate Round, Grant
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 21
  • Round size: Grant $6k–$150k; Private Equity $130M–$4.2B; Corporate Round $100M–$229M
  • Lead/follow: 62% lead, 38% follow

Portfolio highlights

  • Drools — Discover Drools, the best dog food brand offering premium nutrition for your furry friend. Explore our range of healthy, vet-recommended dog food to keep your pet happy and healthy.
  • Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
  • Hsu Fu Chi — Hsu Fu Chi is a confectionery company that manufactures various confectionaries, biscuits, chocolates, jellies, sachima, and snacks.
Show all investments...

M Capital Partners
VC Fund · Toulouse, Midi-Pyrenees, France · 1 investments in Singapore Life Science startups

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Show more...

Investment focus

  • Industry: Health Care, Software, Food and Beverage
  • Stage:Seed, Venture - Series Unknown
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 113
  • Round size: Seed $1.1M–$5.4M; Venture - Series Unknown $1.2M–$5.7M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Haiku — L'IA et la data au service des du droit
  • The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
  • Ascendance — Sustainable flight solutions for today & tomorrow... because cleaner aviation can't wait. With Ascendance, Fly quieter, cleaner, further.
Show all investments...

Arche Investment
VC Fund · 1 investments in Singapore Life Science startups

Arche Investment is an investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Pet, Apps
  • Stage:Series B, Series A
  • Geography: South Korea, Singapore

Investor stats

  • Total investments: 5
  • Round size: Series B $16M–$27M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Cerecin — Cerecin is a healthcare company that develops novel evidence-based therapeutics and products that aim to help people.We develop novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastatingneurological diseases.
  • Kasa — Kasa is a financial service platform that allows people to invest in commercial real estate.
  • Newracle Genetics — Newracle Genetics is a bio venture company that develops gene therapy products for neurological diseases.
Show all investments...

IBK Capital
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups, 14 in the past 12 months

IBK Capital is the venture capital arm of the Industrial Bank of Korea (IBK).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 118
  • Round size: Seed $436k–$4M; Series A $1.8M–$11M; Series B $3M–$17M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • BEYLESS — BEYLESS is an embedded platform for autonomous driving.
  • IHW — iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing.
  • MID — MID specializes in the development, testing, and production of space-related components.
Show all investments...

10X Capital
VC Fund · New York, New York, United States · 1 investments in Singapore Life Science startups

10X invests across the capital structure, alongside the world's top technology investors. They align Wall Street and Silicon Valley by bringing institutional capital to high growth ventures in private and public markets, helping founders and investors achieve scale and liquidity while retaining upside and control.10X was founded in 2004 andis based in New York.

Show more...

Investment focus

  • Industry: Software, Health Care, FinTech
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 263
  • Round size: Seed $1.2M–$6M; Pre-Seed $800k–$5M; Series A $4M–$36M
  • Lead/follow: 2% lead, 98% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Betr — Betr is a direct-to-consumer micro-betting that introduces instant gratification to sports betting. It provides tools to support responsible play and give control over their gambling. It encourages them to use these tools to keep the experience fun and within their personal limits. Betr was founded in 2022 and is based in Miami, Florida.
  • Portal — Build next-generation cell engineering and drug discovery workflows with Portal mechanoporation for broad intracellular delivery across cells and cargoes.
  • CEA Industries — CEA Industries (NASDAQ: BNC) is a publicly traded company pursuing a BNB-focused digital asset treasury strategy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
NPR Holdings
VC Fund · Whitmore Lake, Michigan, United States · 1 investments in Singapore Life Science startups

NPR Holdings

Show more...

Investment focus

  • Industry: Medical, Life Science, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ImmunoScape — ImmuniScape discovers and develops novel TCR-based therapeutics against solid tumors
Show all investments...

Entrepreneurs First
VC Fund · London, England, United Kingdom · 1 investments in Singapore Life Science startups

We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United Kingdom, United States, India

Investor stats

  • Total investments: 447
  • Round size: Seed $567k–$6.7M; Pre-Seed $55k–$2.9M; Series A $5.1M–$30M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely actively investing — fresh fund, raised $133M in 2026

Portfolio highlights

  • Sourcepulse — Your early warning system for software delivery (YC S23)
  • EverSettled — Navigate the probate process with confidence. We provide a free checklist, guidance, and support to help families find clarity in the chaos of loss.
  • Peripheral Labs — Peripheral Labs provides technology for live media and spatial intelligence.
Show all investments...

Enterprise Singapore
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Enterprise Singapore is a government agency that supports enterprise development.The company works with committed companies to build capabilities, innovate and internationalize. Enterprise Singapore also supports the growth of Singapore as a hub for global trading and startups. As the national standards and accreditation body, the companycontinues to build trust in Singapore’s products and services through quality and standards.To enable businesses navigate today’s enterprise landscape, Enterprise Singapore adopts a company-centric approach. Enterprise Singapore do so, by providing programmes and support catered to your company’s stage of growth, the industry you are in, and the overseas markets of your interest.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Singapore, United States, United Kingdom

Investor stats

  • Total investments: 51
  • Round size: Seed $300k–$1.8M; Grant $22k–$585k; Pre-Seed $40k–$300k
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Goldilock — Goldilock is a revolutionary cybersecurity solution that enables users to physically connect and disconnect their digital assets, devices, networks, and critical infrastructure from the internet without using the internet itself. The patented remote security technology ensures that sensitive data remains secure and accessible only when needed
  • Pride Health — Access trusted doctors, e-prescriptions, and discreet medication delivery. Safe, convenient, and judgment-free.
  • 2Strands Biosciences — Better, Cheaper and Faster!
Show all investments...

Gaorong Capital
VC Fund · Wangjing, Beijing, China · 1 investments in Singapore Life Science startups

Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 340
  • Round size: Seed $2.8M–$81M; Series A $2.9M–$75M; Series B $14M–$120M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $185M in 2022

Portfolio highlights

  • Cascade — Cascade produces novel medications that target nuclear receptors for treating metabolic disorders and inflammation.
  • XPENG Robotics — Xpeng Robotics a Shenzen, China-based affiliate of XPeng Inc. and a key part of its mobility ecosystem dedicated to creating smart robots,
  • ALLYRNA Pharmaceuticals — ALLYRNA, an innovative small molecule drug developer focused on first-in-class drug development, has established a unique platform for radiotherapy and immunotherapy sensitizers.
Show all investments...

KT Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups, 7 in the past 12 months

KT Investment, established in 2015 as the venture capital arm of KT Group, is dedicated to driving social impact while achieving maximum investment returns. We stand with founders every step of the way, providing the support and resources necessary to transform innovative ideas into impactful ventures. By partnering with promising startups andventure companies, we create win-win opportunities that pave the way for long-term success. With a global perspective, we actively seek value-driven investments that shape the future.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 87
  • Round size: Series A $2M–$26M; Series B $6.7M–$124M; Series C $8.3M–$109M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Nums AI — Nums AI is a single foundation model that predicts across commerce, healthcare, finance, manufacturing, and defense.
  • MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
  • Twinny — Twinny specializes in the development of self-driving robots.
Show all investments...

Life Science VC funding in Singapore at a glance

Stats across 34 deals from 59 investors.

59
investors
in Singapore Life Science startups
34
deals
in Singapore Life Science startups
$7.7M
median round
in Singapore Life Science startups
53%
lead investors
lead at least one round
21%
Pre-Seed
most common funding stage

Access all 59 VC funds in Singapore Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in Singapore investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 59 VC funds investing in Singapore Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists